SEARCH

SEARCH BY CITATION

References

  • Aucouturier J, Ganne V & Laval A (2000) Efficacy and safety of new adjuvants. Ann NY Acad Sci 916: 600604.
  • Bastos RG, Dellagostin OA, Barletta RG, Doster AR, Nelson E & Osorio FA (2002) Construction and immunogenicity of recombinant Mycobacterium bovis BCG expressing GP5 and M protein of porcine reproductive respiratory syndrome virus. Vaccine 21: 2129.
  • Bowersock TL & Martin S (1999) Vaccine delivery to animals. Adv Drug Deliv Rev 38: 167194.
  • Chen JR, Liao CW, Mao SJ & Weng CN (2001) A recombinant chimera composed of repeat region RR1 of Mycoplasma hyopneumoniae adhesin with Pseudomonas exotoxin: in vivo evaluation of specific IgG response in mice and pigs. Vet Microbiol 80: 347357.
  • Chen AY, Fry SR, Forbes-Faulkner J, Daggard G & Mukkur TK (2006) Evaluation of the immunogenicity of the P97R1 adhesin of Mycoplasma hyopneumoniae as a mucosal vaccine in mice. J Med Microbiol 55: 923929.
  • Chen AY, Fry SR, Daggard GE & Mukkur TK (2008) Evaluation of immune response to recombinant potential protective antigens of Mycoplasma hyopneumoniae delivered as cocktail DNA and/or recombinant protein vaccines in mice. Vaccine 26: 43724378.
  • Conceicao FR, Moreira AN & Dellagostin OA (2006) A recombinant chimera composed of R1 repeat region of Mycoplasma hyopneumoniae P97 adhesin with Escherichia coli heat-labile enterotoxin B subunit elicits immune response in mice. Vaccine 24: 57345743.
  • de Haan A, Geerligs HJ, Huchshorn JP, van Scharrenburg GJ, Palache AM & Wilschut J (1995) Mucosal immunoadjuvant activity of liposomes: induction of systemic IgG and secretory IgA responses in mice by intranasal immunization with an influenza subunit vaccine and coadministered liposomes. Vaccine 13: 155162.
  • de Haan L, Holtrop M, Verweij WR, Agsteribbe E & Wilschut J (1996) Mucosal immunogenicity of the Escherichia coli heat-labile enterotoxin: role of the A subunit. Vaccine 14: 260266.
  • de Haan L, Verweij WR, Feil IK, Holtrop M, Hol WG, Agsteribbe E & Wilschut J (1998) Role of GM1 binding in the mucosal immunogenicity and adjuvant activity of the Escherichia coli heat-labile enterotoxin and its B subunit. Immunology 94: 424430.
  • Djordjevic SP, Cordwell SJ, Djordjevic MA, Wilton J & Minion FC (2004) Proteolytic processing of the Mycoplasma hyopneumoniae cilium adhesin. Infect Immun 72: 27912802.
  • Freund J, Thomson KJ, Hough HB, Sommer HE & Pisani TM (1948) Antibody formation and sensitization with the aid of adjuvants. J Immunol 60: 383398.
  • Gupta RK, Rost BE, Relyveld E & Siber GR (1995) Adjuvant properties of aluminum and calcium compounds. Pharm Biotechnol 6: 229248.
  • Hansson M, Nygren PA & Stahl S (2000) Design and production of recombinant subunit vaccines. Biotechnol Appl Biochem 32(Pt 2): 95107.
  • Harakuni T, Sugawa H, Komesu A, Tadano M & Arakawa T (2005) Heteropentameric cholera toxin B subunit chimeric molecules genetically fused to a vaccine antigen induce systemic and mucosal immune responses: a potential new strategy to target recombinant vaccine antigens to mucosal immune systems. Infect Immun 73: 56545665.
  • Jenkins C, Wilton JL, Minion FC, Falconer L, Walker MJ & Djordjevic SP (2006) Two domains within the Mycoplasma hyopneumoniae cilium adhesin bind heparin. Infect Immun 74: 481487.
  • King KW, Faulds DH, Rosey EL & Yancey RJ Jr (1997) Characterization of the gene encoding Mhp1 from Mycoplasma hyopneumoniae and examination of Mhp1's vaccine potential. Vaccine 15: 2535.
  • Klinkert MQ, Herrmann R & Schaller H (1985) Surface proteins of Mycoplasma hyopneumoniae identified from an Escherichia coli expression plasmid library. Infect Immun 49: 329335.
  • Laemmli UK (1970) Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227: 680685.
  • Minion FC, Adams C & Hsu T (2000) R1 region of P97 mediates adherence of Mycoplasma hyopneumoniae to swine cilia. Infect Immun 68: 30563060.
  • Ogawa Y, Oishi E, Muneta Y, Sano A, Hikono H, Shibahara T, Yagi Y & Shimoji Y (2009) Oral vaccination against mycoplasmal pneumonia of swine using a live Erysipelothrix rhusiopathiae vaccine strain as a vector. Vaccine 27: 45434550.
  • Okamba FR, Moreau E, Cheikh Saad Bouh K, Gagnon CA, Massie B & Arella M (2007) Immune responses induced by replication-defective adenovirus expressing the C-terminal portion of the Mycoplasma hyopneumoniae P97 adhesin. Clin Vaccine Immunol 14: 767774.
  • Okamba FR, Arella M, Music N, Jia JJ, Gottschalk M & Gagnon CA (2010) Potential use of a recombinant replication-defective adenovirus vector carrying the C-terminal portion of the P97 adhesin protein as a vaccine against Mycoplasma hyopneumoniae in swine. Vaccine 28: 48024809.
  • Shimoji Y, Oishi E, Muneta Y, Nosaka H & Mori Y (2003) Vaccine efficacy of the attenuated Erysipelothrix rhusiopathiae YS-19 expressing a recombinant protein of Mycoplasma hyopneumoniae P97 adhesin against mycoplasmal pneumonia of swine. Vaccine 21: 532537.
  • Sixma TK, Pronk SE, Kalk KH, Wartna ES, van Zanten BA, Witholt B & Hol WG (1991) Crystal structure of a cholera toxin-related heat-labile enterotoxin from E. coli. Nature 351: 371377.
  • Sorensen HP & Mortensen KK (2005) Soluble expression of recombinant proteins in the cytoplasm of Escherichia coli. Microb Cell Fact 4: 1.
  • Stevens TL, Bossie A, Sanders VM, Fernandez-Botran R, Coffman RL, Mosmann TR & Vitetta ES (1988) Regulation of antibody isotype secretion by subsets of antigen-specific helper T cells. Nature 334: 255258.
  • Thacker EL (2006) Mycoplasmal diseases. Diseases of Swine, 9th edn (Straw BE, Zimmerman JJ, D'Allaire S, & Taylor DJ, eds), pp. 701717. Blackwell Pub. Professional, Ames, IO.
  • Thacker EL, Thacker BJ, Kuhn M, Hawkins PA & Waters WR (2000) Evaluation of local and systemic immune responses induced by intramuscular injection of a Mycoplasma hyopneumoniae bacterin to pigs. Am J Vet Res 61: 13841389.
  • To H, Someno S, Nagai S, Koyama T & Nagano T (2010) Immunization with truncated recombinant protein SpaC of Erysipelothrix rhusiopathiae strain 715 serovar 18 confers protective immunity against challenge with various serovars. Clin Vaccine Immunol 17: 19911997.
  • Yamashita S, Shi SR & Taylor CR (2011) Antigen Retrieval Immunohistochemistry Based Research and Diagnostics. Wiley, Hoboken, NJ.
  • Zhang Q, Young TF & Ross RF (1995) Identification and characterization of a Mycoplasma hyopneumoniae adhesin. Infect Immun 63: 10131019.